Neuronetics Inc. (NASDAQ: STIM)
$0.6800
-0.0100 ( -1.45% ) 0.0K
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Market Data
Open
$0.6800
Previous close
$0.6900
Volume
0.0K
Market cap
$20.91M
Day range
$0.6810 - $0.6960
52 week range
$0.5200 - $5.0699
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Feb 13, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |
4 | Insider transactions | 1 | Jan 12, 2024 |
8-k | 8K-related | 14 | Jan 08, 2024 |
4 | Insider transactions | 1 | Dec 21, 2023 |
10-q | Quarterly Reports | 85 | Nov 07, 2023 |
8-k | 8K-related | 14 | Nov 07, 2023 |